Piscataqua Savings Bank’s Insight Molecular Diagnostics IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $147 | Hold |
25
| – | – | ﹤0.01% | 406 |
|
|
2026
Q1 | $81 | Hold |
25
| – | – | ﹤0.01% | 413 |
|
|
2025
Q4 | $187 | Hold |
25
| – | – | ﹤0.01% | 400 |
|
|
2025
Q3 | $82 | Hold |
25
| – | – | ﹤0.01% | 349 |
|
|
2025
Q2 | $75 | Hold |
25
| – | – | ﹤0.01% | 367 |
|
|
2025
Q1 | $76 | Hold |
25
| – | – | ﹤0.01% | 336 |
|
|
2024
Q4 | $59 | Hold |
25
| – | – | ﹤0.01% | 345 |
|
|
2024
Q3 | $71 | Hold |
25
| – | – | ﹤0.01% | 345 |
|
|
2024
Q2 | $73 | Hold |
25
| – | – | ﹤0.01% | 347 |
|
|
2024
Q1 | $73 | Hold |
25
| – | – | ﹤0.01% | 402 |
|
|
2023
Q4 | $62 | Hold |
25
| – | – | ﹤0.01% | 349 |
|
|
2023
Q3 | $77 | Hold |
25
| – | – | ﹤0.01% | 353 |
|
|
2023
Q2 | $115 | Hold |
25
| – | – | ﹤0.01% | 346 |
|
|
2023
Q1 | $175 | Hold |
25
| – | – | ﹤0.01% | 352 |
|
|
2022
Q4 | $160 | Hold |
25
| – | – | ﹤0.01% | 342 |
|
|
2022
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 343 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 353 |
|
|
2022
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 346 |
|
|
2021
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 333 |
|
|
2021
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 325 |
|
|
2021
Q2 | $3K | Hold |
25
| – | – | ﹤0.01% | 310 |
|
|
2021
Q1 | $3K | Buy |
+25
| New | +$2.37K | ﹤0.01% | 313 |
|
Other funds holding IMDX
Piscataqua Savings Bank's IMDX Position: Q2 2026 in Review
Piscataqua Savings Bank held its Insight Molecular Diagnostics (IMDX) position steady in Q2 2026 at 25 shares worth $147. The position accounts for ﹤0.01% of the portfolio, ranked #406.
Piscataqua Savings Bank first reported a position in IMDX in Q1 2021 and has held it in 22 quarters since. The position peaked at $3K in Q2 2021. 3 funds tracked by Wall St. Rank hold IMDX as of Q2 2026.
- Piscataqua Savings Bank held 25 shares of Insight Molecular Diagnostics worth $147 as of Q2 2026.
- Piscataqua Savings Bank left its Insight Molecular Diagnostics share count unchanged in Q2 2026.
- Insight Molecular Diagnostics made up ﹤0.01% of Piscataqua Savings Bank's portfolio in Q2 2026, its #406 holding.
- Piscataqua Savings Bank first reported a position in Insight Molecular Diagnostics in Q1 2021 and has held it in 22 quarters since.
- Piscataqua Savings Bank's Insight Molecular Diagnostics position peaked at $3K in Q2 2021.
- 3 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2026.
Based on Piscataqua Savings Bank's 13F filing for Q2 2026, filed 9 Jul 2026.